Oral immunotherapy entails giving people who are allergic to peanuts small doses of protein from the edible seeds. The idea is to desensitize patients to peanuts, freeing them from the risk exposure to a small amount of protein will trigger an allergic reaction. While the approach has its critics, data from NIH-funded trials suggest it can protect kids from the anaphylaxis that would otherwise result from coming into contact with the protein.